28262302|t|Contraction Timing Patterns in Patients Treated for Breast Cancer Before and After Anthracyclines Therapy
28262302|a|During the development of heart failure (HF), the changes of contraction timing pattern and temporal heterogeneity of segmental contraction happen early and may precede both symptomatic HF and the decrease in left ventricular ejection fraction (LVEF). In patients treated with anthracyclines, both symptomatic HF and the decrease of LVEF are detected once significant myocardial injury has occurred. The aim of the current study was to investigate whether changes in the timing of contraction can be detected early after anthracyclines therapy. Forty-one women (50 ± 11 years old) with newly diagnosed breast cancer were prospectively enrolled in two centers and underwent an echocardiogram before and after anthracyclines. Peak longitudinal myocardial systolic strain was measured on the apical four - and two-chamber views. The time to peak systolic longitudinal strain (TP), ejection time (ET), isovolumic contraction time (IVCT), systolic time, and diastolic time were measured using strain curves and Doppler tracings and compared before and after anthracyclines. The heterogeneity of contraction (dyssynchrony) was measured by the SD of the TP of all segments. Anthracyclines treatment was associated with an increase in heart rate (HR) and a decrease in TP. TP was correlated with HR. TP / ET was independent of HR and inversely correlated to peak strain both at baseline and after anthracyclines. TP / ET increased after anthracyclines (1.26 ± 0.19 to 1.31 ± 0.22; P < .001), and this increase was correlated with the decrease in strain. The increase in TP / ET was due to an increase in IVCT / ET. A similar degree of dyssynchrony was found at baseline and after anthracyclines. Anthracyclines treatment induces an increase in the duration of contraction, mainly by increasing the IVCT. This increase is correlated to the decrease in strain and may therefore have additional prognostic value.
28262302	0	11	Contraction	T046	C1140999
28262302	12	27	Timing Patterns	T079	C0439545
28262302	31	39	Patients	T101	C0030705
28262302	40	47	Treated	T061	C0087111
28262302	52	65	Breast Cancer	T191	C0007104
28262302	83	97	Anthracyclines	T109,T195	C0003234
28262302	98	105	Therapy	T061	C0087111
28262302	117	128	development	T169	C1527148
28262302	132	145	heart failure	T047	C0018801
28262302	147	149	HF	T047	C0018801
28262302	156	163	changes	T169	C0392747
28262302	167	178	contraction	T046	C1140999
28262302	179	193	timing pattern	T079	C0439545
28262302	198	206	temporal	T079	C2362314
28262302	207	220	heterogeneity	T080	C0019409
28262302	224	233	segmental	T082	C0205122
28262302	234	245	contraction	T046	C1140999
28262302	280	291	symptomatic	T169	C0231220
28262302	292	294	HF	T047	C0018801
28262302	303	311	decrease	T081	C0547047
28262302	315	349	left ventricular ejection fraction	T201	C0428772
28262302	351	355	LVEF	T201	C0428772
28262302	361	369	patients	T101	C0030705
28262302	370	377	treated	T061	C0087111
28262302	383	397	anthracyclines	T109,T195	C0003234
28262302	404	415	symptomatic	T169	C0231220
28262302	416	418	HF	T047	C0018801
28262302	427	435	decrease	T081	C0547047
28262302	439	443	LVEF	T201	C0428772
28262302	448	456	detected	T033	C0442726
28262302	474	491	myocardial injury	T037	C0746730
28262302	542	553	investigate	T169	C1292732
28262302	562	569	changes	T169	C0392747
28262302	577	583	timing	T079	C0449243
28262302	587	598	contraction	T046	C1140999
28262302	606	614	detected	T033	C0442726
28262302	627	641	anthracyclines	T109,T195	C0003234
28262302	642	649	therapy	T061	C0087111
28262302	661	666	women	T098	C0043210
28262302	698	707	diagnosed	T033	C0011900
28262302	708	721	breast cancer	T191	C0007104
28262302	782	796	echocardiogram	T170	C2243117
28262302	814	828	anthracyclines	T109,T195	C0003234
28262302	830	874	Peak longitudinal myocardial systolic strain	T060	C1868749
28262302	879	887	measured	T081	C0449768
28262302	895	906	apical four	T082	C1302256
28262302	913	930	two-chamber views	T082	C1302267
28262302	936	977	time to peak systolic longitudinal strain	T201	C4263410
28262302	979	981	TP	T201	C4263410
28262302	984	997	ejection time	T201	C0812388
28262302	999	1001	ET	T201	C0812388
28262302	1004	1031	isovolumic contraction time	T079	C2923410
28262302	1033	1037	IVCT	T079	C2923410
28262302	1040	1053	systolic time	T079	C1148547
28262302	1059	1068	diastolic	T201	C0012000
28262302	1069	1073	time	T079	C0040223
28262302	1079	1087	measured	T081	C0449768
28262302	1094	1100	strain	T060	C1868749
28262302	1101	1107	curves	T081	C0392762
28262302	1112	1128	Doppler tracings	T060	C0013523
28262302	1159	1173	anthracyclines	T109,T195	C0003234
28262302	1179	1192	heterogeneity	T080	C0019409
28262302	1196	1207	contraction	T046	C1140999
28262302	1209	1221	dyssynchrony	T047	C3160936
28262302	1227	1235	measured	T081	C0449768
28262302	1253	1255	TP	T201	C4263410
28262302	1273	1287	Anthracyclines	T109,T195	C0003234
28262302	1288	1297	treatment	T061	C0087111
28262302	1302	1317	associated with	T080	C0332281
28262302	1321	1329	increase	T169	C0442805
28262302	1333	1343	heart rate	T201	C0018810
28262302	1345	1347	HR	T201	C0018810
28262302	1355	1363	decrease	T081	C0547047
28262302	1367	1369	TP	T201	C4263410
28262302	1371	1373	TP	T201	C4263410
28262302	1378	1388	correlated	T080	C1707520
28262302	1394	1396	HR	T201	C0018810
28262302	1398	1400	TP	T201	C4263410
28262302	1403	1405	ET	T201	C0812388
28262302	1425	1427	HR	T201	C0018810
28262302	1432	1441	inversely	T080	C0439850
28262302	1442	1452	correlated	T080	C1707520
28262302	1456	1460	peak	T080	C0444505
28262302	1461	1467	strain	T060	C1868749
28262302	1476	1484	baseline	T081	C1442488
28262302	1495	1509	anthracyclines	T109,T195	C0003234
28262302	1511	1513	TP	T201	C4263410
28262302	1516	1518	ET	T201	C0812388
28262302	1519	1528	increased	T081	C0205217
28262302	1535	1549	anthracyclines	T109,T195	C0003234
28262302	1599	1607	increase	T169	C0442805
28262302	1612	1622	correlated	T080	C1707520
28262302	1632	1640	decrease	T081	C0547047
28262302	1644	1650	strain	T060	C1868749
28262302	1656	1664	increase	T169	C0442805
28262302	1668	1670	TP	T201	C4263410
28262302	1673	1675	ET	T201	C0812388
28262302	1690	1698	increase	T169	C0442805
28262302	1702	1706	IVCT	T079	C2923410
28262302	1709	1711	ET	T201	C0812388
28262302	1733	1745	dyssynchrony	T047	C3160936
28262302	1759	1767	baseline	T081	C1442488
28262302	1778	1792	anthracyclines	T109,T195	C0003234
28262302	1794	1808	Anthracyclines	T109,T195	C0003234
28262302	1809	1818	treatment	T061	C0087111
28262302	1819	1826	induces	T169	C0205263
28262302	1830	1838	increase	T169	C0442805
28262302	1858	1869	contraction	T046	C1140999
28262302	1881	1891	increasing	T169	C0442808
28262302	1896	1900	IVCT	T079	C2923410
28262302	1907	1915	increase	T169	C0442805
28262302	1919	1929	correlated	T080	C1707520
28262302	1937	1945	decrease	T081	C0547047
28262302	1949	1955	strain	T060	C1868749
28262302	1990	2006	prognostic value	T201	C1514474